<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01979666</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-12-9707-AL-CTIL</org_study_id>
    <nct_id>NCT01979666</nct_id>
  </id_info>
  <brief_title>Nitrate Patch Use as Treatment of Knee AVN</brief_title>
  <official_title>the Effect of a Nitrate Patch on the Healing Process of AVN of the Knee</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The pathogenesis of AVN includes a defective blood supply to the knee joint. Local nitrates
      induce peripheral vasodilation and may improve blood supply to the affected tissue.

      This study aims to test whether the use of a nicotine patch may accelerate the healing
      process from AVN of the knee.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main purpose of this study is to examine whether treatment with a local nitrate patch
      will improve MRI findings and clinical outcomes in patients with AVN of the knee.

      This is a double-blind prospective study that will include 50 adult volunteers, randomly
      assigned to a &quot;nitrate&quot; group that will be given a nitrate patch, and a &quot;placebo&quot; group that
      will be given a placebo patch.

      The following outcomes will be measured:

        -  MRI findings before and after the patch treatment

        -  Use of analgesics

        -  Subjective pain relief.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in bone substrate edema</measure>
    <time_frame>6 weeks</time_frame>
    <description>the area and percent of the knee which the edema involves</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>other MRI changes</measure>
    <time_frame>6 weeks</time_frame>
    <description>reduction of subchondral fracture resolution of accompanied findings presence of femoral head or condyle flattening</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>analgesics use</measure>
    <time_frame>6 weeks</time_frame>
    <description>according to the patient's self report</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain severity</measure>
    <time_frame>6 weeks</time_frame>
    <description>according to a visual analouge scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Necrosis, Avascular, of Bone</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the patients that will get a nitrate patch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>the patients that will get the placebo patch</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nitrate patch</intervention_name>
    <description>patients in the study group will get a nitrate patch</description>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo patch</intervention_name>
    <description>control group patients will get a placebo patch</description>
    <arm_group_label>control group</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI scan</intervention_name>
    <description>MRI scan after 6 weeks of treatment</description>
    <arm_group_label>study group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
    <other_name>MRI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients (18-80 y.o)

          -  diagnosis of AVN according to MRI

        Exclusion Criteria:

          -  Terminal illness

          -  Cognitive impairment / any condition disturbing informed concent.

          -  Nitrate intolerance

          -  Patients using Cyclic GMP inhibitiors
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>avi livneh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>arik asman, MD</last_name>
    <role>Study Director</role>
    <affiliation>Sheba Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Avi Livneh, MD</last_name>
    <phone>972-3-530-2454</phone>
    <email>avi.livneh@sheba.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Arik Asman, MD</last_name>
    <phone>972-3-530-2454</phone>
    <email>arik.asman@sheba.health.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>arik asman, MD</last_name>
      <phone>972-3-5302454</phone>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2013</study_first_submitted>
  <study_first_submitted_qc>November 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 8, 2013</study_first_posted>
  <last_update_submitted>October 10, 2017</last_update_submitted>
  <last_update_submitted_qc>October 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Prof.Avi Livneh</investigator_full_name>
    <investigator_title>head of internal medicine ward F</investigator_title>
  </responsible_party>
  <keyword>Knee AVN, Nitrates</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Osteonecrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

